Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trialsAndrew F Shorr, Marin Kollef, Paul B Eckburg, et al.
Open Forum Infectious Diseases|May 21, 2024
Impact of Gram-Negative Bacilli Resistance Rates on Risk of Death in Septic Shock and PneumoniaAlison M Hixon, Scott Micek, Victoria J Fraser, et al.
Critical Care (London, England)|February 19, 2024
Understanding the nebulisation of antibiotics: the key role of lung microdialysis studiesJayesh Dhanani, Jason A Roberts, Antoine Monsel, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2019
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or MeropenemAdam M Blevins, Jennifer N Lashinsky, Craig McCammon, et al.
Clinical Therapeutics|July 28, 2014
Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot studyScott T Micek, Heather Arnold, Paul Juang, et al.
Critical Care Medicine|April 19, 2011
Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsisMichael T Johnson, Richard Reichley, Joan Hoppe-Bauer, et al.
Infection Control and Hospital Epidemiology|February 1, 2007
Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrheaKathleen M McMullen, Jeanne Zack, Craig M Coopersmith, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|December 24, 2011
Toward a two-tier clinical warning system for hospitalized patientsGregory Hackmann, Minmin Chen, Octav Chipara, et al.
Critical Care Medicine|May 16, 2012
The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*Andrew Labelle, Paul Juang, Richard Reichley, et al.
Pageof 7